Clinical Research Directory
Browse clinical research sites, groups, and studies.
Platelet Rich Plasma Testis Treatment for Infertile Men
Sponsor: Stanford University
Summary
Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.
Official title: Platelet Rich Plasma Testis
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2023-01-18
Completion Date
2026-12-31
Last Updated
2026-01-13
Healthy Volunteers
No
Interventions
Platelet rich plasma
Patients will undergo a blood draw (12 tsp) to prepare the PRP infusion. The use of a centrifuge and an Arteriocyte Magellan kit are necessary for the PRP preparation. After injection of local anesthesia, PRP will be injected into each testicle. * On the third month after the testicular PRP procedure, a TESE will be performed * If the procedure is successful a new IVF cycle using the sperm procured from the procedure will be done.
Locations (1)
Stanford Urology Clinic
Stanford, California, United States